Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia

被引:2195
作者
Weng, AP
Ferrando, AA
Lee, W
Morris, JP
Silverman, LB
Sanchez-Irizarry, C
Blacklow, SC
Look, AT
Aster, JC [1 ]
机构
[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA
[2] Harvard Univ, Dana Farber Canc Inst, Sch Med, Dept Pediat Oncol, Boston, MA 02115 USA
关键词
D O I
10.1126/science.1102160
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Very rare cases of human T cell acute lymphoblastic leukemia (T-ALL) harbor chromosomal translocations that involve NOTCH1, a gene encoding a transmembrane receptor that regulates normal T cell development. Here, we report that more than 50% of human T-ALLs, including tumors from all major molecular oncogenic subtypes, have activating mutations that involve the extracellular heterodimerization domain and/or the C-terminal PEST domain of NOTCH1. These findings greatly expand the role of activated NOTCH1 in the molecular pathogenesis of human T-ALL and provide a strong rationale for targeted therapies that interfere with NOTCH signaling.
引用
收藏
页码:269 / 271
页数:3
相关论文
共 25 条
[21]   p300 and PCA act cooperatively to mediate transcriptional activation from chromatin templates by Notch intracellular domains in vitro [J].
Wallberg, AE ;
Pedersen, K ;
Lendahl, U ;
Roeder, RG .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (22) :7812-7819
[22]   Growth suppression of pre-T acute lymphoblastic leukemia cells by inhibition of notch signaling [J].
Weng, AP ;
Nam, Y ;
Wolfe, MS ;
Pear, WNS ;
Griffin, JD ;
Blacklow, SC ;
Aster, JC .
MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (02) :655-664
[23]   Therapeutic strategies for Alzheimer's disease [J].
Wolfe, MS .
NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (11) :859-866
[24]   Inactivation of Notch2 impairs VDJβ rearrangement and allows pre-TCR-independent survival of early αβ lineage thymocytes [J].
Wolfer, A ;
Wilson, A ;
Nemir, M ;
MacDonald, HR ;
Radtke, F .
IMMUNITY, 2002, 16 (06) :869-879
[25]   Chronic treatment with the γ-secretase inhibitor LY-411,575 inhibits β-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation [J].
Wong, GT ;
Manfra, D ;
Poulet, FM ;
Zhang, Q ;
Josien, H ;
Bara, T ;
Engstrom, L ;
Pinzon-Ortiz, M ;
Fine, JS ;
Lee, HJJ ;
Zhang, LL ;
Higgins, GA ;
Parker, EM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (13) :12876-12882